CXCR6 Is a Marker for Protective Antigen-Specific Cells in the Lungs after Intranasal Immunization against Mycobacterium tuberculosis

CXCR6 Is a Marker for Protective Antigen-Specific Cells in the Lungs after Intranasal Immunization against Mycobacterium tuberculosis

Show other versions (1)

Bibliographic Details
Main Authors:	Lee, L, Ronan, E, de Lara, C, Franken, K, Ottenhoff, T, Tchilian, E, Beverley, P
Format:	Journal article
Published:	2011

Similar Items

CXCR6 is a marker for protective antigen-specific cells in the lungs after intranasal immunization against Mycobacterium tuberculosis.
by: Lee, L, et al.
Published: (2011)

Immunization with different formulations of Mycobacterium tuberculosis antigen 85A induces immune responses with different specificity and protective efficacy
by: Tchilian, E, et al.
Published: (2013)

Immunization with different formulations of Mycobacterium tuberculosis antigen 85A induces immune responses with different specificity and protective efficacy
by: Tchilian, E, et al.
Published: (2013)

Immunization with different formulations of Mycobacterium tuberculosis antigen 85A induces immune responses with different specificity and protective efficacy.
by: Tchilian, E, et al.
Published: (2013)

Simultaneous immunization against tuberculosis.
by: Tchilian, E, et al.
Published: (2011)

Simultaneous immunization against tuberculosis.
by: Tchilian, E, et al.
Published: (2011)

Identification of T-cell antigens specific for latent mycobacterium tuberculosis infection.
by: Sebastian D Schuck, et al.
Published: (2009-01-01)

Multifunctional, high-level cytokine-producing Th1 cells in the lung, but not spleen, correlate with protection against Mycobacterium tuberculosis aerosol challenge in mice.
by: Forbes, E, et al.
Published: (2008)

Nasal associated lymphoid tissue (NALT) contributes little to protection against aerosol challenge with Mycobacterium tuberculosis after immunisation with a recombinant adenoviral vaccine.
by: Ronan, E, et al.
Published: (2010)

Nasal associated lymphoid tissue (NALT) contributes little to protection against aerosol challenge with Mycobacterium tuberculosis after immunisation with a recombinant adenoviral vaccine.
by: Ronan, E, et al.
Published: (2010)

Environmental effects on protection against Mycobacterium tuberculosis after immunization with Ad85A.
by: Beverley, P, et al.
Published: (2013)

Antigens of Mycobacterium tuberculosis Stimulate CXCR6+ Natural Killer Cells
by: José Alberto Choreño-Parra, et al.
Published: (2020-09-01)

Immunization of mice with a recombinant adenovirus vaccine inhibits the early growth of Mycobacterium tuberculosis after infection.
by: Ronan, E, et al.
Published: (2009)

Immunization of Mice with a Recombinant Adenovirus Vaccine Inhibits the Early Growth of Mycobacterium tuberculosis After Infection
by: Ronan, E, et al.
Published: (2009)

Kinetics of T cell-activation molecules in response to Mycobacterium tuberculosis antigens
by: Antas Paulo RZ, et al.
Published: (2002-01-01)

Significance of Antigen and Epitope Specificity in Tuberculosis
by: Juraj eIvanyi, et al.
Published: (2014-10-01)

Design of Polymeric Nanocapsules for Intranasal Vaccination against Mycobacterium Tuberculosis: Influence of the Polymeric Shell and Antigen Positioning
by: Lara Diego-González, et al.
Published: (2020-05-01)

Potential of DosR and Rpf antigens from Mycobacterium tuberculosis to discriminate between latent and active tuberculosis in a tuberculosis endemic population of Medellin Colombia
by: Leonar Arroyo, et al.
Published: (2018-01-01)

Understanding vaccine induced protective immunity to Mycobacterium tuberculosis
by: Ronan, E
Published: (2011)

Immunogenicity of 60 novel latency-related antigens of Mycobacterium tuberculosis
by: Mªdel Mar eSerra Vidal, et al.
Published: (2014-10-01)

A novel murine cytomegalovirus vaccine vector protects against Mycobacterium tuberculosis.
by: Beverley, P, et al.
Published: (2014)

Immunization of mice with a recombinant adenovirus vaccine inhibits the early growth of Mycobacterium tuberculosis after infection.
by: Edward O Ronan, et al.
Published: (2009-12-01)

Recognition of stage-specific mycobacterial antigens differentiates between acute and latent infections with Mycobacterium tuberculosis.
by: Demissie, A, et al.
Published: (2006)

In-vivo expressed Mycobacterium tuberculosis antigens recognised in three mouse strains after infection and BCG vaccination
by: Mariateresa Coppola, et al.
Published: (2021-06-01)

Dimethyl fumarate eliminates differentially culturable Mycobacterium tuberculosis in an intranasal murine model of tuberculosis
by: Sarah M. Glenn, et al.
Published: (2022-08-01)

The In Vivo Transcriptomic Blueprint of Mycobacterium tuberculosis in the Lung
by: Mariateresa Coppola, et al.
Published: (2021-12-01)

CXCR6-Deficiency Improves the Control of Pulmonary Mycobacterium tuberculosis and Influenza Infection Independent of T-Lymphocyte Recruitment to the Lungs
by: Anneliese S. Ashhurst, et al.
Published: (2019-03-01)

A Systematic Review on Novel Mycobacterium tuberculosis Antigens and Their Discriminatory Potential for the Diagnosis of Latent and Active Tuberculosis
by: Noëmi R. Meier, et al.
Published: (2018-11-01)

Chemokine gene expression in lung CD8 T cells correlates with protective immunity in mice immunized intra-nasally with Adenovirus-85A.
by: Lee, L, et al.
Published: (2010)

The T cell response to lipid antigens of Mycobacterium tuberculosis
by: Gennaro eDe Libero, et al.
Published: (2014-05-01)

Lessons for tuberculosis vaccines from respiratory virus infection.
by: Beverley, P, et al.
Published: (2008)

Lessons for tuberculosis vaccines from respiratory virus infection
by: Beverley, P, et al.
Published: (2008)

Immunogenicity and protective efficacy of prime-boost regimens with recombinant (delta)ureC hly+ Mycobacterium bovis BCG and modified vaccinia virus ankara expressing M. tuberculosis antigen 85A against murine tuberculosis.
by: Tchilian, E, et al.
Published: (2009)

Rapid detection of Mycobacterium tuberculosis infection by enumeration of antigen-specific T cells.
by: Lalvani, A, et al.
Published: (2001)

Antigen-specific chemokine profiles as biomarkers for detecting Mycobacterium tuberculosis infection
by: Weicong Ren, et al.
Published: (2024-03-01)

Erratum: Immunogenicity and protective efficacy of prime-boost regimens with recombinant δureC hly+ Mycobacterium bovis BCG and modified Vaccinia virus Ankara expressing M. tuberculosis antigen 85A against murine tuberculosis
by: Tchilian, E, et al.
Published: (2011)

Cellular immune responses to nine Mycobacterium tuberculosis vaccine candidates following intranasal vaccination.
by: Suraj B Sable, et al.
Published: (2011-01-01)

MHC Ib molecule Qa-1 presents Mycobacterium tuberculosis peptide antigens to CD8+ T cells and contributes to protection against infection.
by: Yao Bian, et al.
Published: (2017-05-01)

Reactogenicity to major tuberculosis antigens absent in BCG is linked to improved protection against Mycobacterium tuberculosis
by: Nacho Aguilo, et al.
Published: (2017-07-01)

Identification of major factors influencing ELISpot-based monitoring of cellular responses to antigens from Mycobacterium tuberculosis.
by: Smith, S, et al.
Published: (2009)